Monitoring carboplatin ototoxicity with distortion-product otoacoustic emissions in children with retinoblastoma

OBJECTIVE: Carboplatin is a common chemotherapy agent with potential ototoxic side effects that is used to treat a variety of pediatric cancers, including retinoblastoma. Retinoblastoma is a malignant tumor of the retina that is usually diagnosed in young children. Distortion-product otoacoustic emi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Pediatr Otorhinolaryngol
Autores principales: Bhagat, Shaum P., Bass, Johnnie K., White, Stephanie T., Qaddoumi, Ibrahim, Wilson, Matthew W., Wu, Jianrong, Rodriguez-Galindo, Carlos
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4787621/
https://ncbi.nlm.nih.gov/pubmed/20667604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijporl.2010.07.004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares